Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Insulin Glargine U 300

Brand: Toujeo┬«
NICE TA: 
Indication: Type 1 diabetes mellitus
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

Insulin glargine 300 units/mL (Toujeo®) is recommended as an option in adults with type 1 diabetes mellitus (T1DM) only in accordance with the recommendations in NICE NG17 and in those who experience an unacceptable frequency and/or severity of nocturnal hypoglycaemia on attempting to achieve better glycaemic control during treatment with first-line long-acting insulin analogues; or as a once daily insulin therapy for patients who require assistance with administering injections.

Recommendation

LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

LMMG New Medicine Assessment - Insulin Glargine U300 T1DM (315.0 KiB)

Insulin Toujeo Information Sheet And Good Practice Guide (Version 1.1) (255.8 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber0

Amber

Amber0

Amber0

Amber0

Amber0